Literature DB >> 8941011

Metastatic phenotype correlates with high expression of membrane-associated complete beta-human chorionic gonadotropin in vivo.

H F Acevedo1, R J Hartsock.   

Abstract

BACKGROUND: Investigations using living human cancer cells and the nude mouse model were conducted to evaluate the expression of human chorionic gonadotropin (hCG) in various cancers grown in vitro and in vivo. The aim was to determine whether membrane-associated hCG in any of its forms is a characteristic metastatic marker, and at what levels or ratios.
METHODS: Human cancer cell lines known to produce tumors that metastasize spontaneously when grown in nude mice (n = 4) were compared with those that do not produce such tumors (n = 4) using analytical (quantitative) flow cytometry. Monoclonal antibodies directed to epitopes of intact hCG (hCG-holo) and its subunits, including beta-human chorionic gonadotropin with its carboxy-terminal peptide (hCG beta-CTP), allowed for the determination of hCG beta-CTP/hCG-holo ratios.
RESULTS: No significant difference in hCG beta-CTP/hCG-holo ratios was found between the cultured human cancer cells that do not metastasize spontaneously (ratio = 2.39) and those that do (ratio = 2.13), and no difference was seen in their growth rate in nude mice. However, the cells isolated from tumors that do not metastasize spontaneously showed a decrease in their ratios to values less than 1. They reverted to their original values after reestablishment in culture and subsequent passages. In contrast, the ratios shown by cells isolated from tumors that metastasize spontaneously increased to 3 to 6 times their original values in culture, then reverted to their original values after reestablishment in culture and subsequent passages.
CONCLUSIONS: To our knowledge, these data demonstrate the following for the first time: 1) There is a direct in vivo correlation between human cancer cells that metastasize spontaneously in nude mice and the expression of membrane-associated complete hCG beta (hCG beta-CTP); and the correlation identifies this molecule as a characteristic metastatic phenotype marker. 2) The marked ratio variations under different conditions indicate that the metastatic phenotype is an unstable event. 3) Growth and local invasion in vivo correlates with the expression of hCG-holo.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8941011     DOI: 10.1002/(sici)1097-0142(19961201)78:11<2388::aid-cncr18>3.0.co;2-x

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  8 in total

1.  HCG variants, the growth factors which drive human malignancies.

Authors:  Laurence A Cole
Journal:  Am J Cancer Res       Date:  2011-11-20       Impact factor: 6.166

2.  Beta-human Chorionic Gonadotropin-secreting Lung Adenocarcinoma.

Authors:  Yin Ping Wong; Geok Chin Tan; Suraya Aziz; Sucharit Pongprakyun; Fuad Ismail
Journal:  Malays J Med Sci       Date:  2015 Jul-Aug

Review 3.  Extragonadal actions of chorionic gonadotropin.

Authors:  Prajna Banerjee; Asgerally T Fazleabas
Journal:  Rev Endocr Metab Disord       Date:  2011-12       Impact factor: 6.514

Review 4.  New discoveries on the biology and detection of human chorionic gonadotropin.

Authors:  Laurence A Cole
Journal:  Reprod Biol Endocrinol       Date:  2009-01-26       Impact factor: 5.211

Review 5.  Biological functions of hCG and hCG-related molecules.

Authors:  Laurence A Cole
Journal:  Reprod Biol Endocrinol       Date:  2010-08-24       Impact factor: 5.211

Review 6.  Unconventional Actions of Glycoprotein Hormone Subunits: A Comprehensive Review.

Authors:  Bruno Querat
Journal:  Front Endocrinol (Lausanne)       Date:  2021-09-21       Impact factor: 5.555

7.  Transgenesis-mediated reproductive dysfunction and tumorigenesis: effects of immunological neutralization.

Authors:  Ruchi Sachdeva; Neetu Bhardwaj; Ilpo Huhtaniemi; Usha Aggrawal; Swatantra Kumar Jain; Rana Zaidi; Om Singh; Rahul Pal
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

8.  Gonadotropin-mediated chemoresistance: Delineation of molecular pathways and targets.

Authors:  Suchismita Sahoo; Poonam Singh; Beneeta Kalha; Om Singh; Rahul Pal
Journal:  BMC Cancer       Date:  2015-11-25       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.